TipRanks
Celcuity (CELC)
NASDAQ:CELC
US Market
CELC
Celcuity
RESEARCH TOOLSreports
Want to see CELC full AI Analyst Report?

Celcuity (CELC) Stock News & Sentiment

555 Followers
Celcuity Files sNDA to Expand REVTORPYK Breast Cancer Use
Premium
Company Announcements
Celcuity Files sNDA to Expand REVTORPYK Breast Cancer Use
23d ago
8K
CELC
Celcuity Inc. Earnings Call: Revtopik Launch Set Stage
Premium
Company Announcements
Celcuity Inc. Earnings Call: Revtopik Launch Set Stage
25d ago
CELC
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
Premium
Ratings
Celcuity Initiation: Launch Timing Shift Seen as Low Risk, Buy Rating Reiterated on Strong Launch Readiness and Demand Outlook
1M ago
CELC
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
Premium
Ratings
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
1M ago
CELC
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
Premium
Ratings
Price Target Trimmed to $140 as Revtorpyk Launch and Gedatolisib Breast Cancer Opportunity Support Buy Rating
1M ago
CELC
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CELC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CELC
Celcuity: Buy Rating Reaffirmed on Gedatolisib’s Multi-Billion-Dollar Potential, $165 Price Target Unchanged
Premium
Ratings
Celcuity: Buy Rating Reaffirmed on Gedatolisib’s Multi-Billion-Dollar Potential, $165 Price Target Unchanged
2M ago
CELC
More CELC News >

CELC News on the Web

Celcuity Inc. at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral
Perceptive Advisors LLC Expands LeonaBio Inc (LONA) Stake in Strategic Add
GuruFocus News
Neutral
Celcuity (CELC): Landmark Approval Collides With A Costly Launch
Insider Monkey
Neutral
TANG CAPITAL MANAGEMENT LLC Buys Nano Dimension Ltd (NNDM) -- Shares Look 69% Undervalued on GF ...
GuruFocus News
Neutral
SILVERARC CAPITAL MANAGEMENT, LLC Trims Elutia Inc (ELUT) Stake -- Shares Look 11% Overvalued ...
GuruFocus News
Neutral
SilverArc Capital Management Exits KalVista Pharmaceuticals (KALV) Position Entirely
GuruFocus News
Neutral
SILVERARC CAPITAL MANAGEMENT, LLC Trims TELA Bio Inc (TELA) Stake -- Shares Trade 55% Below GF Value
GuruFocus News
Neutral
Unchanged $165 Target as Gedatolisib’s Strong Clinical Profile and FDA Approval Support Buy Rating
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CELC
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CELC’s Media Buzz Sentiment?
2 articles about CELC were published this week. In an average week, 4.5 articles are published.
    What is CELC’s weekly average amount of articles?
    In an average week, 4.5 articles about CELC are published.
      What is CELC’s News Sentiment?
      100% of articles about CELC were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SLDBSolid Biosciences
        CRLCharles River Labs
        ASNDAscendis Pharma
        CRBPCorbus Pharmaceuticals
        RVMDRevolution Medicines
        Showing the stocks with the most bullish news sentiment over the past week